Welf. & Inst. Code, § 14195.9 · Article 6.1. Medi-Cal Therapeutic Drug Utilization Review

Welf. & Inst. Code, § 14195.9

Verbatim from the official edition

Text — As published in the Legislative Counsel's database, tables dated October 18, 2026 (pubinfo_2025.zip)

In no case shall the director’s discretion under Section 14120 be exercised to reduce reimbursement to providers of pharmaceutical services because of increased costs in the drug component of the Medi-Cal program arising from the implementation of the open formulary concept.

Notes and commentary — not statutory text

History

Added by Stats. 1984, Ch. 1636, Sec. 5.

Source of truth

Edition: As published in the Legislative Counsel's database, tables dated October 18, 2026 (pubinfo_2025.zip)
Official file: https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?lawCode=WIC&sectionNum=14195.9.
Text hash: sha256 2b5df57e441d3a4f9631cda3e8bb34a85d2e267612f24af99999643b4ddf30a5
Composed by: compose_ca.py 2026-10-22: the Legislative Counsel's CAML content files read by a tokenizer (caml_readers.reader_a); an independent xml.etree reading (caml_readers.reader_b) agrees on every section

This section cites

Provisions in this library that the text above cites, as it prints each citation. A range cited as “ss. 61.13-61.16” links its first and last provisions.

Welfare and Institutions Code

Welf. & Inst. Code, § 14120Printed as Section 14120

Procedural information only. Not legal advice and not a substitute for the advice of an attorney. Confirm the current text with the official publisher before relying on it.